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Emerging evidence suggests a potential contribution of neutrophil extracellular traps (NETs) in linking sterile inflammation and thrombosis (4, 7, 12) . We and others (6, 9) recently demonstrated the existence of NETs after myocardial ischemic challenge and confirmed the therapeutic potential of NETtargeted interventions in ameliorating myocardial ischemia/ reperfusion injury. Additionally, we hypothesized that the formation of NETs may be associated with coronary microcirculation obstruction, which is a major reason leading to coronary "no-reflow" phenomenon in clinical practice. To this end, we used thioflavin S and Evans blue staining, a classical method for detecting the anatomic no-reflow in experimental research, which revealed that DNase I combined with tissuetype plasminogen activator (a thrombolytic agent) could reduce anatomic no-reflow area.
In Tanaka and colleagues' recent work (10) , with the aid of two photon laser-scanning microscopy, they observed two forms of intravascular NETs, i.e., circulating cell-free NETs and anchored NETs, in various organs of lipopolysaccharidechallenged mouse model, and they noted reduced intravascular NETs by DNase in real time. Therefore, they suggested the use of intravital imaging technique in the investigation of NETmediated myocardial microcirculation obstruction and coronary no-reflow (11) .
We totally agree with Dr. Tanaka and colleagues' invaluable suggestion and highly appreciate their elegant work in the field of NET-mediated thrombosis (10) . The intravital imaging technique should be incorporated in future studies to evaluated the dynamics of coronary NET formation, which may provide important information for translational purpose in humans, such as the time frame for effective interventions.
Since the first publication of NETs as a novel innate defense mechanism against infections in 2004 (2), the past decade has witnessed growing interest of the participation of NETs in varieties of disease processes. Enlightened by the pioneer work by Wagner's group (5), mounting evidence suggests a critical role of NETs in human coronary heart disease (1, 3) . Notably, a recent work demonstrated that coronary NET burden in patients suffering acute ST-elevation coronary syndrome is an independent predictor for increased infarct size (8) . Thus these findings undoubtedly open a new avenue for basic and translational researches for NET-targeted interventions in acute coronary syndrome, one of the leading causes of morbidity and mortality worldwide.
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